☆ 4.6 Article

The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2

JOURNAL OF FUNGI (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Endocrinology & Metabolism

Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India

Awadhesh Kumar Singh et al.

Summary: This systematic review analyzed the characteristics of patients with both COVID-19 and mucormycosis, finding a high proportion of cases in males, 80% with pre-existing diabetes, and a significant use of corticosteroids in treating COVID-19, contributing to mortality in some cases.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

添加到收藏夹

Letter Infectious Diseases

Outbreak of Candida auris infection in a COVID-19 hospital in Mexico

Hiram Villanueva-Lozano et al.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Review Microbiology

Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update

Carolina Ferreira et al.

Summary: The composition of gut microbiota may play a role in the severity of COVID-19 infection, as it is related to immune system response, gastrointestinal symptoms, and the virus receptor ACE2. Patients with pre-existing chronic diseases are more likely to have dysbiosis in gut microbiota, and those with severe outcomes often exhibit hyperresponsiveness of the immune system and a cytokine storm, which may be associated with impaired microbiota phenotype.

MICROORGANISMS (2021)

添加到收藏夹

Article Immunology

COVID-19 Impairs Immune Response to Candida albicans

Dominique Moser et al.

Summary: COVID-19 patients with ARDS show abnormal immune phenotypes and cytokine levels, indicating a potential risk for secondary infections. They demonstrate an increased susceptibility to Aspergillus infection and exhibit aberrant immune response towards Candida albicans.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Editorial Material Microbiology

Environmental Candida auris and the Global Warming Emergence Hypothesis

Arturo Casadevall et al.

Summary: Global warming has been suggested as a contributing factor to the simultaneous emergence of Candida auris as a nosocomial pathogen on different continents. Isolating C. auris from the remote Andaman Islands supports the hypothesis that it is an environmental organism. The slower growth of one environmental isolate at mammalian temperatures suggests recent thermal adaptation, potentially due to climate change.

MBIO (2021)

添加到收藏夹

Article Microbiology

Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit

Joao N. de Almeida et al.

Summary: In December 2020, Candida auris emerged in Brazil, with the first two patients colonized in the same COVID-19 intensive care unit. Antifungal susceptibility testing showed low minimal inhibitory concentrations for various drugs. Microsatellite typing revealed clonal strains belonging to the South Asian clade of C. auris. The hypothesis is that the species was introduced several months before the first recognized case and/or emerged locally in the coastline Salvador area during the COVID-19 pandemic.

JOURNAL OF FUNGI (2021)

添加到收藏夹

Letter Infectious Diseases

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?

Arnaud Fekkar et al.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Dermatology

Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids

Joao Nobrega de Almeida Jr et al.

Summary: This study investigated Trichosporon asahii fungemia among critically ill COVID-19 patients in a Brazilian referral centre from July to September 2020. Five patients developed TAF, with common risk conditions. The use of voriconazole therapy was common, with a high 30-day mortality rate. The T asahii strains had low minimal inhibitory concentrations for azole derivatives. Judicious prescription of antibiotics, corticosteroids, and antifungals is important in preventing infections by hard-to-treat fungi like T asahii in critically ill COVID-19 patients.

MYCOSES (2021)

添加到收藏夹

Article Medicine, Research & Experimental

COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management

Farah Yasmin et al.

Summary: The COVID-19 pandemic has led to an increase in cases of mucormycosis in patients, causing worse prognosis and challenges in diagnosis and treatment. Limited guidelines for screening and management have raised concerns among healthcare professionals about the potential threat of an epidemic alongside the pandemic.

DISEASES (2021)

添加到收藏夹

Review Medicine, General & Internal

A Report of Candida blankii Fungemia and Possible Endocarditis in an Immunocompetent Individual and the Review of Literature

Vidya S. Kollu et al.

Summary: Candida blankii, an emerging pathogenic fungus, has been identified in immunocompromised patients causing fungemia. This study reports a case of C. blankii fungemia in an immunocompetent individual, successfully treated with a combination of antifungal agents. Further research is needed due to the variable susceptibility pattern and lack of treatment guidelines for this organism.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

添加到收藏夹

Article Immunology

COVID-19-Associated Pulmonary Aspergillosis, March-August 2020

Jon Salmanton-Garcia et al.

Summary: This study found that most patients with coronavirus disease-associated pulmonary aspergillosis (CAPA) are diagnosed shortly after admission, with the majority being treated in the ICU. Azole-resistant strains of Aspergillus fumigatus were common in patients, and voriconazole was the main treatment choice. The overall mortality rate was approximately 52.2%, with about one third of deaths attributed to CAPA.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Candida blankii: an emerging yeast in an outbreak of fungaemia in neonates in Delhi, India

A. Chowdhary et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

添加到收藏夹

Article Infectious Diseases

MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method

Andrew M. Borman et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

添加到收藏夹

Article Infectious Diseases

Fungal diseases as neglected pathogens: A wake-up call to public health officials

Marcio L. Rodrigues et al.

PLOS NEGLECTED TROPICAL DISEASES (2020)

添加到收藏夹

Letter Critical Care Medicine

COVID-19-associated invasive pulmonary aspergillosis

Lynn Rutsaert et al.

ANNALS OF INTENSIVE CARE (2020)

添加到收藏夹

Article Microbiology

Bloodstream Infection bySaccharomyces cerevisiaein Two COVID-19 Patients after Receiving Supplementation ofSaccharomycesin the ICU

Ioannis Ventoulis et al.

JOURNAL OF FUNGI (2020)

添加到收藏夹

Letter Immunology

Candida blankii: an emergent opportunistic yeast with reduced susceptibility to antifungals

Joao Nobrega de Almeida et al.

EMERGING MICROBES & INFECTIONS (2018)

添加到收藏夹

Article Respiratory System

318 Candida blankii : New agent in cystic fibrosis airways?

S. Zaragoza et al.

Journal of Cystic Fibrosis (2015)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.